Endogenous beta3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000627:Aminophenols / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000378:metabolism; D004285:Dogs; D006333:Heart Failure / Q000188:drug therapy / Q000378:metabolism*; D009200:Myocardial Contraction / Q000502:physiology; D032383:Myocytes, Cardiac / Q000378:metabolism*; D010138:Pacemaker, Artificial; D022702:Receptors, Adrenergic, beta-3 / Q000378:metabolism*; D013449:Sulfonamides / Q000494:pharmacology; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy / Q000378:metabolism*
D000319:Adrenergic beta-Antagonists; D000627:Aminophenols; C120576:L 748,337; D022702:Receptors, Adrenergic, beta-3; D013449:Sulfonamides; D002118:Calcium